Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Third Arc Bio teams up with Adagene to create T-cell engagers
Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers.
Gabrielle Masson
Nov 13, 2025 10:45am
Illumina shares rise as China set to lift sequencer export ban
Nov 6, 2025 9:50am
Illumina sales flat in Q3 amid China headwinds
Oct 31, 2025 8:55am
Roche pens $1B deal for respiratory bispecific from China
Oct 30, 2025 5:04am
China pricing pressure weighs on Roche's diagnostics business
Oct 23, 2025 8:40am
Hansoh, Chugai ink separate and lucrative licensing agreements
Oct 17, 2025 11:04am
